25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

INDISA (Inst Diagnosti) Stock Analysis
Buy, Hold or Sell?

Let's analyze Inst Diagnosti together

I guess you are interested in Inst Diagnosti. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Inst Diagnosti’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Inst Diagnosti’s Price Targets

I'm going to help you getting a better view of Inst Diagnosti. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Inst Diagnosti

I send you an email if I find something interesting about Inst Diagnosti.

1. Quick Overview

1.1. Quick analysis of Inst Diagnosti (30 sec.)










1.2. What can you expect buying and holding a share of Inst Diagnosti? (30 sec.)

How much money do you get?

How much money do you get?
β‚±0.00
When do you have the money?
1 year
How often do you get paid?
70.0%

What is your share worth?

Current worth
β‚±784.43
Expected worth in 1 year
β‚±828.65
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
β‚±44.22
Return On Investment
2.0%

For what price can you sell your share?

Current Price per Share
β‚±2,165.90
Expected price per share
β‚±1,898 - β‚±2,203
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Inst Diagnosti (5 min.)




Live pricePrice per Share (EOD)
β‚±2,165.90
Intrinsic Value Per Share
β‚±6,439.95 - β‚±7,714.13
Total Value Per Share
β‚±7,224.38 - β‚±8,498.55

2.2. Growth of Inst Diagnosti (5 min.)




Is Inst Diagnosti growing?

Current yearPrevious yearGrowGrow %
How rich?$121.6m$113.6m$5.6m4.7%

How much money is Inst Diagnosti making?

Current yearPrevious yearGrowGrow %
Making money$2.3m$951.6k$1.4m60.1%
Net Profit Margin3.5%1.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Inst Diagnosti (5 min.)




2.4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#95 / 170

Most Revenue
#110 / 170

Most Profit
#93 / 170
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Inst Diagnosti?

Welcome investor! Inst Diagnosti's management wants to use your money to grow the business. In return you get a share of Inst Diagnosti.

First you should know what it really means to hold a share of Inst Diagnosti. And how you can make/lose money.

Speculation

The Price per Share of Inst Diagnosti is β‚±2,166. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inst Diagnosti.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inst Diagnosti, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is β‚±784.43. Based on the TTM, the Book Value Change Per Share is β‚±11.05 per quarter. Based on the YOY, the Book Value Change Per Share is β‚±9.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is β‚±0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inst Diagnosti.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚±% of Price per Shareβ‚±% of Price per Shareβ‚±% of Price per Shareβ‚±% of Price per Shareβ‚±% of Price per Shareβ‚±% of Price per Share
Usd Eps0.020.0%0.020.0%0.010.0%0.010.0%0.020.0%0.020.0%
Usd Book Value Change Per Share0.010.0%0.010.0%0.010.0%0.010.0%0.010.0%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.020.0%0.030.0%0.030.0%
Usd Total Gains Per Share0.010.0%0.010.0%0.020.0%0.030.0%0.040.0%0.060.0%
Usd Price Per Share2.37-1.39-1.46-1.49-1.59-1.89-
Price to Earnings Ratio38.05-20.73-84.88-47.72-33.20-32.00-
Price-to-Total Gains Ratio217.45-155.22-385.52-206.76-138.55-112.99-
Price to Book Ratio2.74-1.64-1.81-1.84-2.11-2.82-
Price-to-Total Gains Ratio217.45-155.22-385.52-206.76-138.55-112.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.38249
Number of shares419
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.010.04
Gains per Quarter (419 shares)5.1015.80
Gains per Year (419 shares)20.3863.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102010451853
2041309037116
30615013555179
40827017973242
501029022492305
60122110269110368
70143130314128431
80163150359147494
90183170404165557
100204190449183620

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%29.01.00.096.7%29.01.00.096.7%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%17.03.00.085.0%27.03.00.090.0%27.03.00.090.0%
Dividend per Share0.00.04.00.0%5.00.07.041.7%13.00.07.065.0%21.00.09.070.0%21.00.09.070.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%30.00.00.0100.0%30.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Inst Diagnosti compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--9.88711.055-11%9.467+4%7.420+33%9.951-1%26.148-62%
Book Value Per Share--784.429769.725+2%733.363+7%739.264+6%696.135+13%644.911+22%
Current Ratio--1.1231.169-4%1.137-1%1.154-3%1.129-1%1.271-12%
Debt To Asset Ratio--0.6210.608+2%0.6210%0.617+1%0.595+4%0.574+8%
Debt To Equity Ratio--1.6391.552+6%1.6420%1.614+2%1.485+10%1.372+19%
Dividend Per Share----0%6.950-100%15.367-100%24.330-100%28.489-100%
Enterprise Value--121763227900.00067818282096.667+80%17720927023.350+587%39688441551.236+207%68262928659.937+78%124519739477.034-2%
Eps--14.12515.381-8%6.139+130%12.625+12%17.741-20%18.967-26%
Ev To Sales Ratio--0.4950.276+79%0.079+523%0.180+174%0.391+27%0.804-38%
Free Cash Flow Per Share--70.73731.865+122%36.888+92%25.857+174%5.994+1080%7.510+842%
Free Cash Flow To Equity Per Share--70.73731.865+122%24.320+191%6.309+1021%4.169+1597%1.229+5658%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7714.126----------
Intrinsic Value_10Y_min--6439.950----------
Intrinsic Value_1Y_max--200.630----------
Intrinsic Value_1Y_min--196.730----------
Intrinsic Value_3Y_max--1039.031----------
Intrinsic Value_3Y_min--983.138----------
Intrinsic Value_5Y_max--2403.348----------
Intrinsic Value_5Y_min--2193.181----------
Market Cap305240287000.000+1%303000071900.000178452949322.500+70%187433730523.350+62%190779649921.967+59%203727383226.940+49%242042999594.467+25%
Net Profit Margin--0.0320.035-8%0.015+113%0.025+31%0.044-27%0.057-43%
Operating Margin----0%0.006-100%0.016-100%0.042-100%0.070-100%
Operating Ratio--1.6971.686+1%1.738-2%1.731-2%1.708-1%1.677+1%
Pb Ratio2.761+1%2.7411.644+67%1.813+51%1.835+49%2.109+30%2.821-3%
Pe Ratio38.336+1%38.05420.729+84%84.883-55%47.718-20%33.197+15%32.000+19%
Price Per Share2165.900+1%2150.0001266.250+70%1329.975+62%1353.717+59%1445.590+49%1717.467+25%
Price To Free Cash Flow Ratio7.655+1%7.5997.878-4%15.448-51%2.313+228%17.380-56%8.755-13%
Price To Total Gains Ratio219.061+1%217.453155.222+40%385.516-44%206.762+5%138.548+57%112.985+92%
Quick Ratio--0.6340.661-4%0.710-11%0.731-13%0.763-17%0.852-26%
Return On Assets--0.0070.008-13%0.003+116%0.005+31%0.010-30%0.013-46%
Return On Equity--0.0180.020-10%0.008+116%0.013+36%0.024-23%0.029-38%
Total Gains Per Share--9.88711.055-11%16.417-40%22.786-57%34.281-71%54.637-82%
Usd Book Value--121604731.600119325262.100+2%113688359.400+7%114603179.533+6%107917101.875+13%99976148.103+22%
Usd Book Value Change Per Share--0.0110.012-11%0.010+4%0.008+33%0.011-1%0.029-62%
Usd Book Value Per Share--0.8630.847+2%0.807+7%0.813+6%0.766+13%0.709+22%
Usd Dividend Per Share----0%0.008-100%0.017-100%0.027-100%0.031-100%
Usd Enterprise Value--133939550.69074600110.306+80%19493019.726+587%43657285.706+207%75089221.526+78%136971713.425-2%
Usd Eps--0.0160.017-8%0.007+130%0.014+12%0.020-20%0.021-26%
Usd Free Cash Flow--10965871.4004939782.375+122%5718423.975+92%4008394.408+174%929282.255+1080%1164177.190+842%
Usd Free Cash Flow Per Share--0.0780.035+122%0.041+92%0.028+174%0.007+1080%0.008+842%
Usd Free Cash Flow To Equity Per Share--0.0780.035+122%0.027+191%0.007+1021%0.005+1597%0.001+5658%
Usd Market Cap335764315.700+1%333300079.090196298244.255+70%206177103.576+62%209857614.914+59%224100121.550+49%266247299.554+25%
Usd Price Per Share2.382+1%2.3651.393+70%1.463+62%1.489+59%1.590+49%1.889+25%
Usd Profit--2189636.9002384345.150-8%951622.925+130%1538956.650+42%2499356.090-12%2773007.233-21%
Usd Revenue--67696827.00067505602.725+0%62047321.050+9%60951663.208+11%55240826.080+23%50226840.620+35%
Usd Total Gains Per Share--0.0110.012-11%0.018-40%0.025-57%0.038-71%0.060-82%
 EOD+4 -4MRQTTM+17 -18YOY+28 -103Y+26 -125Y+18 -2010Y+15 -23

3.3 Fundamental Score

Let's check the fundamental score of Inst Diagnosti based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1538.336
Price to Book Ratio (EOD)Between0-12.761
Net Profit Margin (MRQ)Greater than00.032
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.634
Current Ratio (MRQ)Greater than11.123
Debt to Asset Ratio (MRQ)Less than10.621
Debt to Equity Ratio (MRQ)Less than11.639
Return on Equity (MRQ)Greater than0.150.018
Return on Assets (MRQ)Greater than0.050.007
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Inst Diagnosti based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2,165.900
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Inst Diagnosti

Instituto de DiagnΓ³stico S.A. provides health services in Chile. It offers patient information and indication exams, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising online consultation and rehabilitation. In addition, it operates health centers, which includes metabolic surgery and nutrition, thyroid and parathyroid, physical medicine and rehabilitation, endometriosis, hemodynamics service, and dialysis centers. Further, the company offers research and training services, as well as newborn, school, and accident agreements. Instituto de DiagnΓ³stico S.A. was founded in 1961 and is headquartered in Providencia, Chile.

Fundamental data was last updated by Penke on 2025-06-30 04:27:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Inst Diagnosti earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Inst Diagnosti to theΒ Medical Care Facilities industry mean.
  • A Net Profit Margin of 3.2%Β means thatΒ $0.03 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Inst Diagnosti:

  • The MRQ is 3.2%. The company is making a profit. +1
  • The TTM is 3.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.2%TTM3.5%-0.3%
TTM3.5%YOY1.5%+2.0%
TTM3.5%5Y4.4%-0.9%
5Y4.4%10Y5.7%-1.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2%3.8%-0.6%
TTM3.5%3.4%+0.1%
YOY1.5%2.6%-1.1%
3Y2.5%2.7%-0.2%
5Y4.4%3.2%+1.2%
10Y5.7%3.8%+1.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Inst Diagnosti is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Inst Diagnosti to theΒ Medical Care Facilities industry mean.
  • 0.7% Return on Assets means thatΒ Inst Diagnosti generatedΒ $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Inst Diagnosti:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.8%-0.1%
TTM0.8%YOY0.3%+0.5%
TTM0.8%5Y1.0%-0.2%
5Y1.0%10Y1.3%-0.3%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%1.0%-0.3%
TTM0.8%0.9%-0.1%
YOY0.3%1.2%-0.9%
3Y0.5%0.9%-0.4%
5Y1.0%0.9%+0.1%
10Y1.3%1.0%+0.3%
4.3.1.3. Return on Equity

Shows how efficient Inst Diagnosti is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Inst Diagnosti to theΒ Medical Care Facilities industry mean.
  • 1.8% Return on Equity means Inst Diagnosti generated $0.02Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Inst Diagnosti:

  • The MRQ is 1.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM2.0%-0.2%
TTM2.0%YOY0.8%+1.2%
TTM2.0%5Y2.4%-0.3%
5Y2.4%10Y2.9%-0.5%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%2.7%-0.9%
TTM2.0%2.4%-0.4%
YOY0.8%3.0%-2.2%
3Y1.3%2.5%-1.2%
5Y2.4%2.4%0.0%
10Y2.9%2.7%+0.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Inst Diagnosti.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Inst Diagnosti is operatingΒ .

  • Measures how much profit Inst Diagnosti makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Inst Diagnosti to theΒ Medical Care Facilities industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Inst Diagnosti:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY0.6%-0.6%
TTM-5Y4.2%-4.2%
5Y4.2%10Y7.0%-2.7%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-6.2%
TTM-6.6%-6.6%
YOY0.6%6.2%-5.6%
3Y1.6%5.6%-4.0%
5Y4.2%6.4%-2.2%
10Y7.0%7.5%-0.5%
4.3.2.2. Operating Ratio

Measures how efficient Inst Diagnosti is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Care Facilities industry mean).
  • An Operation Ratio of 1.70 means that the operating costs are $1.70 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Inst Diagnosti:

  • The MRQ is 1.697. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.686. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.697TTM1.686+0.011
TTM1.686YOY1.738-0.052
TTM1.6865Y1.708-0.022
5Y1.70810Y1.677+0.031
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6971.266+0.431
TTM1.6861.103+0.583
YOY1.7380.999+0.739
3Y1.7311.061+0.670
5Y1.7081.014+0.694
10Y1.6770.998+0.679
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Inst Diagnosti.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Inst Diagnosti is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Care Facilities industry mean).
  • A Current Ratio of 1.12Β means the company has $1.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Inst Diagnosti:

  • The MRQ is 1.123. The company is just able to pay all its short-term debts.
  • The TTM is 1.169. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.123TTM1.169-0.046
TTM1.169YOY1.137+0.033
TTM1.1695Y1.129+0.040
5Y1.12910Y1.271-0.142
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1231.283-0.160
TTM1.1691.260-0.091
YOY1.1371.320-0.183
3Y1.1541.346-0.192
5Y1.1291.400-0.271
10Y1.2711.423-0.152
4.4.3.2. Quick Ratio

Measures if Inst Diagnosti is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Inst Diagnosti to theΒ Medical Care Facilities industry mean.
  • A Quick Ratio of 0.63Β means the company can pay off $0.63 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Inst Diagnosti:

  • The MRQ is 0.634. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.661. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.634TTM0.661-0.027
TTM0.661YOY0.710-0.049
TTM0.6615Y0.763-0.102
5Y0.76310Y0.852-0.089
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6340.642-0.008
TTM0.6610.773-0.112
YOY0.7100.874-0.164
3Y0.7310.950-0.219
5Y0.7631.084-0.321
10Y0.8521.173-0.321
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Inst Diagnosti.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Inst DiagnostiΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Inst Diagnosti to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.62Β means that Inst Diagnosti assets areΒ financed with 62.1% credit (debt) and the remaining percentage (100% - 62.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Inst Diagnosti:

  • The MRQ is 0.621. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.608. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.621TTM0.608+0.013
TTM0.608YOY0.621-0.014
TTM0.6085Y0.595+0.013
5Y0.59510Y0.574+0.021
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6210.505+0.116
TTM0.6080.501+0.107
YOY0.6210.487+0.134
3Y0.6170.492+0.125
5Y0.5950.519+0.076
10Y0.5740.531+0.043
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Inst Diagnosti is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Inst Diagnosti to theΒ Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 163.9% means that company has $1.64 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Inst Diagnosti:

  • The MRQ is 1.639. The company is just able to pay all its debts with equity.
  • The TTM is 1.552. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.639TTM1.552+0.087
TTM1.552YOY1.642-0.090
TTM1.5525Y1.485+0.068
5Y1.48510Y1.372+0.113
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6390.968+0.671
TTM1.5520.934+0.618
YOY1.6420.927+0.715
3Y1.6140.968+0.646
5Y1.4851.096+0.389
10Y1.3721.160+0.212
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Inst Diagnosti generates.

  • Above 15 is considered overpriced butΒ always compareΒ Inst Diagnosti to theΒ Medical Care Facilities industry mean.
  • A PE ratio of 38.05 means the investor is paying $38.05Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Inst Diagnosti:

  • The EOD is 38.336. Based on the earnings, the company is overpriced. -1
  • The MRQ is 38.054. Based on the earnings, the company is overpriced. -1
  • The TTM is 20.729. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD38.336MRQ38.054+0.281
MRQ38.054TTM20.729+17.326
TTM20.729YOY84.883-64.155
TTM20.7295Y33.197-12.468
5Y33.19710Y32.000+1.197
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD38.33614.803+23.533
MRQ38.05415.772+22.282
TTM20.72913.534+7.195
YOY84.88315.376+69.507
3Y47.71815.549+32.169
5Y33.19716.300+16.897
10Y32.00021.057+10.943
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Inst Diagnosti:

  • The EOD is 7.655. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.599. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.878. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.655MRQ7.599+0.056
MRQ7.599TTM7.878-0.280
TTM7.878YOY15.448-7.569
TTM7.8785Y17.380-9.501
5Y17.38010Y8.755+8.624
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD7.6557.909-0.254
MRQ7.5997.601-0.002
TTM7.8786.835+1.043
YOY15.4487.737+7.711
3Y2.3137.176-4.863
5Y17.3807.207+10.173
10Y8.7558.755+0.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Inst Diagnosti is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 2.74 means the investor is paying $2.74Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Inst Diagnosti:

  • The EOD is 2.761. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.741. Based on the equity, the company is underpriced. +1
  • The TTM is 1.644. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.761MRQ2.741+0.020
MRQ2.741TTM1.644+1.097
TTM1.644YOY1.813-0.169
TTM1.6445Y2.109-0.465
5Y2.10910Y2.821-0.711
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD2.7611.733+1.028
MRQ2.7411.725+1.016
TTM1.6441.826-0.182
YOY1.8132.142-0.329
3Y1.8352.082-0.247
5Y2.1092.472-0.363
10Y2.8212.877-0.056
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in CLP. All numbers in thousands.

Summary
Total Assets291,786,600
Total Liabilities181,236,844
Total Stockholder Equity110,549,756
 As reported
Total Liabilities 181,236,844
Total Stockholder Equity+ 110,549,756
Total Assets = 291,786,600

Assets

Total Assets291,786,600
Total Current Assets98,650,492
Long-term Assets193,136,108
Total Current Assets
Cash And Cash Equivalents 13,961,800
Short-term Investments 233,356
Net Receivables 55,428,765
Inventory 2,631,846
Total Current Assets  (as reported)98,650,492
Total Current Assets  (calculated)72,255,767
+/- 26,394,725
Long-term Assets
Property Plant Equipment 149,561,751
Intangible Assets 8,870,795
Long-term Assets  (as reported)193,136,108
Long-term Assets  (calculated)158,432,546
+/- 34,703,562

Liabilities & Shareholders' Equity

Total Current Liabilities87,836,864
Long-term Liabilities93,399,980
Total Stockholder Equity110,549,756
Total Current Liabilities
Short Long Term Debt 18,202,959
Accounts payable 46,240,777
Total Current Liabilities  (as reported)87,836,864
Total Current Liabilities  (calculated)64,443,736
+/- 23,393,128
Long-term Liabilities
Long term Debt 73,850,922
Capital Lease Obligations Min Short Term Debt12,155,785
Long-term Liabilities  (as reported)93,399,980
Long-term Liabilities  (calculated)86,006,707
+/- 7,393,273
Total Stockholder Equity
Retained Earnings 47,500,785
Total Stockholder Equity (as reported)110,549,756
Total Stockholder Equity (calculated)47,500,785
+/- 63,048,971
Other
Capital Stock59,578,197
Common Stock Shares Outstanding 140,930
Net Debt 78,092,081
Net Invested Capital 202,603,637
Net Working Capital 10,813,628
Property Plant and Equipment Gross 234,407,837



6.2. Balance Sheets Structured

Currency in CLP. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
> Total Assets 
159,857,439
160,779,625
157,895,171
162,697,923
163,502,063
166,267,395
161,282,376
164,422,100
168,494,230
171,960,297
177,949,929
181,319,177
182,724,885
193,338,814
199,089,750
214,636,553
230,876,134
256,746,457
259,958,839
261,832,809
272,964,718
271,712,655
272,677,632
270,773,492
276,574,934
272,237,372
272,196,267
271,127,777
272,435,941
291,786,600
291,786,600272,435,941271,127,777272,196,267272,237,372276,574,934270,773,492272,677,632271,712,655272,964,718261,832,809259,958,839256,746,457230,876,134214,636,553199,089,750193,338,814182,724,885181,319,177177,949,929171,960,297168,494,230164,422,100161,282,376166,267,395163,502,063162,697,923157,895,171160,779,625159,857,439
   > Total Current Assets 
64,494,967
63,667,875
60,714,401
64,862,016
65,281,563
67,233,856
62,898,750
65,968,483
66,904,919
67,572,649
71,509,716
75,436,394
71,363,478
79,437,523
79,092,082
79,662,046
86,216,536
95,177,606
94,339,127
93,385,523
99,252,869
94,868,051
95,500,535
92,617,590
99,633,557
95,382,075
96,801,973
96,394,338
98,835,935
98,650,492
98,650,49298,835,93596,394,33896,801,97395,382,07599,633,55792,617,59095,500,53594,868,05199,252,86993,385,52394,339,12795,177,60686,216,53679,662,04679,092,08279,437,52371,363,47875,436,39471,509,71667,572,64966,904,91965,968,48362,898,75067,233,85665,281,56364,862,01660,714,40163,667,87564,494,967
       Cash And Cash Equivalents 
14,325,548
16,868,435
15,697,561
15,690,185
17,768,414
18,299,802
11,911,466
12,137,208
13,578,780
13,257,314
20,914,420
21,096,107
15,064,632
15,979,994
16,451,442
9,674,804
9,751,239
15,905,502
11,139,316
9,702,837
14,188,761
13,298,735
15,228,078
13,111,550
12,762,811
16,106,080
16,634,924
16,582,671
10,651,346
13,961,800
13,961,80010,651,34616,582,67116,634,92416,106,08012,762,81113,111,55015,228,07813,298,73514,188,7619,702,83711,139,31615,905,5029,751,2399,674,80416,451,44215,979,99415,064,63221,096,10720,914,42013,257,31413,578,78012,137,20811,911,46618,299,80217,768,41415,690,18515,697,56116,868,43514,325,548
       Short-term Investments 
0
0
0
0
0
349
343
316
295
0
0
0
0
0
0
0
316,197
321,277
0
0
0
0
0
0
0
0
0
0
228,988
233,356
233,356228,9880000000000321,277316,197000000029531634334900000
       Net Receivables 
46,843,802
42,831,925
43,888,000
48,067,945
45,562,652
33,168,267
35,055,115
36,312,153
50,160,677
50,286,674
46,481,962
50,302,067
52,295,541
59,082,075
60,223,716
65,888,778
72,101,625
74,346,272
78,745,058
79,158,183
58,323,944
51,253,348
76,439,726
54,119,562
59,041,928
50,852,486
53,130,747
51,670,858
60,213,330
55,428,765
55,428,76560,213,33051,670,85853,130,74750,852,48659,041,92854,119,56276,439,72651,253,34858,323,94479,158,18378,745,05874,346,27272,101,62565,888,77860,223,71659,082,07552,295,54150,302,06746,481,96250,286,67450,160,67736,312,15335,055,11533,168,26745,562,65248,067,94543,888,00042,831,92546,843,802
       Inventory 
1,135,387
1,177,144
1,128,494
1,103,521
1,152,777
1,127,856
1,175,527
1,291,178
1,401,471
1,863,716
2,685,360
2,389,064
2,353,204
2,514,894
2,416,924
2,551,971
2,704,845
3,078,827
3,067,284
2,886,732
3,663,908
3,474,770
3,259,999
2,964,564
3,024,176
3,110,873
3,332,475
3,128,966
2,760,223
2,631,846
2,631,8462,760,2233,128,9663,332,4753,110,8733,024,1762,964,5643,259,9993,474,7703,663,9082,886,7323,067,2843,078,8272,704,8452,551,9712,416,9242,514,8942,353,2042,389,0642,685,3601,863,7161,401,4711,291,1781,175,5271,127,8561,152,7771,103,5211,128,4941,177,1441,135,387
       Other Current Assets 
2,189,682
2,789,982
0
0
797,390
994,597
1,108,613
1,296,098
1,763,696
2,164,945
1,427,974
1,649,156
1,650,101
1,860,560
0
1,546,493
1,658,827
1,847,005
1,387,469
1,526,904
0
0
572,732
0
0
0
0
0
0
0
0000000572,732001,526,9041,387,4691,847,0051,658,8271,546,49301,860,5601,650,1011,649,1561,427,9742,164,9451,763,6961,296,0981,108,613994,597797,390002,789,9822,189,682
   > Long-term Assets 
0
0
0
0
0
99,033,539
98,383,626
98,453,617
101,589,311
104,387,648
106,440,213
105,882,783
111,361,407
113,901,291
119,997,668
134,974,507
144,659,598
161,568,851
165,619,712
168,447,286
173,711,849
176,844,604
177,177,097
178,155,902
176,941,377
176,855,297
175,394,294
174,733,439
173,600,006
193,136,108
193,136,108173,600,006174,733,439175,394,294176,855,297176,941,377178,155,902177,177,097176,844,604173,711,849168,447,286165,619,712161,568,851144,659,598134,974,507119,997,668113,901,291111,361,407105,882,783106,440,213104,387,648101,589,31198,453,61798,383,62699,033,53900000
       Property Plant Equipment 
88,844,688
90,398,128
90,163,551
90,472,251
90,021,435
91,116,091
90,995,357
91,014,573
93,857,935
96,338,392
97,340,740
96,254,774
101,204,629
103,300,550
108,399,210
120,785,447
130,641,956
140,518,203
145,546,030
149,088,455
153,470,675
155,407,951
154,921,801
154,826,145
153,735,310
152,003,050
150,517,109
149,443,251
148,155,642
149,561,751
149,561,751148,155,642149,443,251150,517,109152,003,050153,735,310154,826,145154,921,801155,407,951153,470,675149,088,455145,546,030140,518,203130,641,956120,785,447108,399,210103,300,550101,204,62996,254,77497,340,74096,338,39293,857,93591,014,57390,995,35791,116,09190,021,43590,472,25190,163,55190,398,12888,844,688
       Long Term Investments 
4,193,619
4,374,400
4,476,359
4,741,917
4,725,123
4,960,676
4,630,510
4,892,253
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000004,892,2534,630,5104,960,6764,725,1234,741,9174,476,3594,374,4004,193,619
       Intangible Assets 
714,156
735,569
823,217
833,215
1,042,603
1,058,396
809,429
701,374
603,759
549,791
504,433
721,772
962,546
1,250,096
1,852,092
2,542,314
3,055,160
3,865,630
4,624,389
5,327,550
5,996,260
6,601,518
7,134,959
7,662,161
8,363,906
8,680,890
9,008,515
8,983,676
8,922,571
8,870,795
8,870,7958,922,5718,983,6769,008,5158,680,8908,363,9067,662,1617,134,9596,601,5185,996,2605,327,5504,624,3893,865,6303,055,1602,542,3141,852,0921,250,096962,546721,772504,433549,791603,759701,374809,4291,058,3961,042,603833,215823,217735,569714,156
       Long-term Assets Other 
0
0
0
0
0
99,033,539
98,383,626
98,453,617
101,589,311
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000101,589,31198,453,61798,383,62699,033,53900000
> Total Liabilities 
90,861,354
90,638,145
84,992,505
87,902,896
87,418,723
88,976,154
82,274,011
83,567,241
86,576,463
89,458,031
96,022,598
98,230,366
97,899,992
106,278,053
109,573,908
122,309,404
135,710,235
158,744,522
159,517,361
160,062,037
171,263,730
172,731,649
170,267,493
168,109,000
172,555,181
167,919,540
165,780,540
163,339,567
163,279,590
181,236,844
181,236,844163,279,590163,339,567165,780,540167,919,540172,555,181168,109,000170,267,493172,731,649171,263,730160,062,037159,517,361158,744,522135,710,235122,309,404109,573,908106,278,05397,899,99298,230,36696,022,59889,458,03186,576,46383,567,24182,274,01188,976,15487,418,72387,902,89684,992,50590,638,14590,861,354
   > Total Current Liabilities 
43,571,773
43,059,971
37,014,270
40,649,649
41,393,967
42,855,173
37,601,171
39,963,488
44,658,196
48,572,411
56,573,732
57,548,342
58,869,014
67,681,841
73,077,029
81,781,234
95,889,979
115,884,096
75,168,044
78,164,023
88,356,335
90,077,037
88,315,515
77,702,723
88,743,225
82,883,414
81,198,743
81,933,639
83,346,707
87,836,864
87,836,86483,346,70781,933,63981,198,74382,883,41488,743,22577,702,72388,315,51590,077,03788,356,33578,164,02375,168,044115,884,09695,889,97981,781,23473,077,02967,681,84158,869,01457,548,34256,573,73248,572,41144,658,19639,963,48837,601,17142,855,17341,393,96740,649,64937,014,27043,059,97143,571,773
       Short-term Debt 
6,904,120
6,761,042
4,758,649
4,958,769
5,091,384
5,457,552
5,567,830
6,125,619
10,424,701
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000010,424,7016,125,6195,567,8305,457,5525,091,3844,958,7694,758,6496,761,0426,904,120
       Short Long Term Debt 
6,904,120
6,761,042
4,758,649
4,958,769
5,091,384
5,457,552
5,567,830
6,125,619
10,424,701
12,942,918
26,194,765
24,711,008
21,977,586
26,419,441
32,713,742
35,277,603
42,477,773
59,439,269
22,543,595
22,544,326
28,148,672
29,662,265
29,513,634
20,696,815
25,663,122
21,398,611
22,652,539
22,399,271
20,591,846
18,202,959
18,202,95920,591,84622,399,27122,652,53921,398,61125,663,12220,696,81529,513,63429,662,26528,148,67222,544,32622,543,59559,439,26942,477,77335,277,60332,713,74226,419,44121,977,58624,711,00826,194,76512,942,91810,424,7016,125,6195,567,8305,457,5525,091,3844,958,7694,758,6496,761,0426,904,120
       Accounts payable 
3,996,559
4,027,519
4,200,680
4,196,246
3,795,219
11,807,403
11,481,330
11,944,256
4,004,890
3,827,657
3,747,725
6,686,801
4,538,914
4,391,653
4,956,333
4,785,929
4,697,001
4,551,536
5,584,853
4,665,622
38,875,033
39,677,798
6,605,190
24,253,114
45,801,660
43,480,106
39,612,416
39,697,017
41,826,967
46,240,777
46,240,77741,826,96739,697,01739,612,41643,480,10645,801,66024,253,1146,605,19039,677,79838,875,0334,665,6225,584,8534,551,5364,697,0014,785,9294,956,3334,391,6534,538,9146,686,8013,747,7253,827,6574,004,89011,944,25611,481,33011,807,4033,795,2194,196,2464,200,6804,027,5193,996,559
       Other Current Liabilities 
17,327,053
17,174,987
13,651,014
17,037,640
17,836,906
18,073,734
12,528,063
14,002,627
14,609,502
16,763,405
13,863,726
11,525,448
15,311,928
19,843,074
19,044,398
22,524,498
27,074,556
28,661,605
21,854,084
24,646,143
0
0
24,053,531
0
0
0
0
0
0
0
000000024,053,5310024,646,14321,854,08428,661,60527,074,55622,524,49819,044,39819,843,07415,311,92811,525,44813,863,72616,763,40514,609,50214,002,62712,528,06318,073,73417,836,90617,037,64013,651,01417,174,98717,327,053
   > Long-term Liabilities 
0
0
0
0
0
46,120,981
44,672,840
43,603,753
41,918,267
40,885,620
39,448,866
40,682,024
39,030,978
38,596,212
36,496,879
40,528,170
39,820,256
42,860,426
84,349,317
81,898,014
82,907,395
82,654,612
81,951,978
90,406,277
83,811,956
85,036,126
84,581,797
81,405,928
79,932,883
93,399,980
93,399,98079,932,88381,405,92884,581,79785,036,12683,811,95690,406,27781,951,97882,654,61282,907,39581,898,01484,349,31742,860,42639,820,25640,528,17036,496,87938,596,21239,030,97840,682,02439,448,86640,885,62041,918,26743,603,75344,672,84046,120,98100000
       Capital Lease Obligations 
0
0
0
0
0
8,611,882
9,049,815
8,952,102
8,261,739
8,531,683
8,157,832
7,580,549
7,547,089
8,024,229
7,730,841
7,268,256
8,618,894
14,137,159
14,014,055
13,853,541
14,019,876
14,845,987
13,911,854
13,289,167
13,122,264
12,477,813
11,678,937
11,307,369
10,503,321
12,155,785
12,155,78510,503,32111,307,36911,678,93712,477,81313,122,26413,289,16713,911,85414,845,98714,019,87613,853,54114,014,05514,137,1598,618,8947,268,2567,730,8418,024,2297,547,0897,580,5498,157,8328,531,6838,261,7398,952,1029,049,8158,611,88200000
       Deferred Long Term Liability 
0
0
0
0
583,217
334,568
132,212
22,444
0
0
0
0
0
0
0
398,403
355,711
297,369
301,590
15,651
0
0
0
0
0
0
0
0
0
0
000000000015,651301,590297,369355,711398,403000000022,444132,212334,568583,2170000
> Total Stockholder Equity
68,996,085
70,141,480
72,902,666
74,795,027
76,083,340
77,291,241
79,008,365
80,854,859
81,917,767
82,502,266
81,927,331
83,088,811
84,824,893
87,060,761
89,515,842
92,327,149
95,165,899
98,001,935
100,441,478
101,770,772
101,700,988
98,981,006
102,410,139
102,664,492
104,019,753
104,317,832
106,415,727
107,788,210
109,156,351
110,549,756
110,549,756109,156,351107,788,210106,415,727104,317,832104,019,753102,664,492102,410,13998,981,006101,700,988101,770,772100,441,47898,001,93595,165,89992,327,14989,515,84287,060,76184,824,89383,088,81181,927,33182,502,26681,917,76780,854,85979,008,36577,291,24176,083,34074,795,02772,902,66670,141,48068,996,085
   Common Stock
12,342,475
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
59,578,197
0
0
59,578,197
0
0
0
0
0
0
0
000000059,578,1970059,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19759,578,19712,342,475
   Retained Earnings 
53,182,836
7,092,509
9,853,695
11,746,056
13,034,369
14,242,270
15,959,394
17,805,888
18,868,796
19,453,295
18,878,360
20,039,840
21,775,922
24,011,790
26,466,871
29,278,178
32,116,928
34,952,964
37,392,507
38,721,801
38,652,017
35,932,035
39,361,168
39,615,521
40,970,782
41,268,861
43,366,756
44,739,239
46,107,380
47,500,785
47,500,78546,107,38044,739,23943,366,75641,268,86140,970,78239,615,52139,361,16835,932,03538,652,01738,721,80137,392,50734,952,96432,116,92829,278,17826,466,87124,011,79021,775,92220,039,84018,878,36019,453,29518,868,79617,805,88815,959,39414,242,27013,034,36911,746,0569,853,6957,092,50953,182,836
   Capital Surplus 000000000000000000000000000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
3,301,340
0
0
3,301,340
0
0
0
0
0
0
0
00000003,301,340003,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,3403,301,340



6.3. Balance Sheets

Currency in CLP. All numbers in thousands.




6.4. Cash Flows

Currency in CLP. All numbers in thousands.




6.5. Income Statements

Currency in CLP. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CLP. All numbers in thousands.

Gross Profit (+$)
totalRevenue239,071,048
Cost of Revenue-180,957,846
Gross Profit58,113,20258,113,202
 
Operating Income (+$)
Gross Profit58,113,202
Operating Expense-224,416,232
Operating Income14,654,816-166,303,030
 
Operating Expense (+$)
Research Development0
Selling General Administrative23,830,754
Selling And Marketing Expenses0
Operating Expense224,416,23223,830,754
 
Net Interest Income (+$)
Interest Income835,415
Interest Expense-7,616,844
Other Finance Cost-180
Net Interest Income-6,781,609
 
Pretax Income (+$)
Operating Income14,654,816
Net Interest Income-6,781,609
Other Non-Operating Income Expenses0
Income Before Tax (EBT)7,991,54014,654,816
EBIT - interestExpense = -7,616,844
7,275,926
14,892,770
Interest Expense7,616,844
Earnings Before Interest and Taxes (EBIT)015,608,384
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax7,991,540
Tax Provision-715,614
Net Income From Continuing Ops7,275,9267,275,926
Net Income7,275,926
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net06,781,609
 

Technical Analysis of Inst Diagnosti
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inst Diagnosti. The general trend of Inst Diagnosti is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inst Diagnosti's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Inst Diagnosti Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Inst Diagnosti.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2,132 < 2,164 < 2,203.

The bearish price targets are: 2,026 > 1,983 > 1,898.

Know someone who trades $INDISA? Share this with them.πŸ‘‡

Inst Diagnosti Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Inst Diagnosti. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Inst Diagnosti Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Inst Diagnosti.

Inst Diagnosti Daily Moving Average Convergence/Divergence (MACD) ChartInst Diagnosti Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Inst Diagnosti. The current adx is .

Inst Diagnosti Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Inst Diagnosti.

Inst Diagnosti Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Inst Diagnosti.

Inst Diagnosti Daily Relative Strength Index (RSI) ChartInst Diagnosti Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Inst Diagnosti.

Inst Diagnosti Daily Stochastic Oscillator ChartInst Diagnosti Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Inst Diagnosti.

Inst Diagnosti Daily Commodity Channel Index (CCI) ChartInst Diagnosti Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Inst Diagnosti.

Inst Diagnosti Daily Chande Momentum Oscillator (CMO) ChartInst Diagnosti Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Inst Diagnosti.

Inst Diagnosti Daily Williams %R ChartInst Diagnosti Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Inst Diagnosti.

Inst Diagnosti Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Inst Diagnosti.

Inst Diagnosti Daily Average True Range (ATR) ChartInst Diagnosti Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Inst Diagnosti.

Inst Diagnosti Daily On-Balance Volume (OBV) ChartInst Diagnosti Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Inst Diagnosti.

Inst Diagnosti Daily Money Flow Index (MFI) ChartInst Diagnosti Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Inst Diagnosti.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Inst Diagnosti Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Inst Diagnosti based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2,165.900
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Inst Diagnosti with someone you think should read this too:
  • Are you bullish or bearish on Inst Diagnosti? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inst Diagnosti? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Inst Diagnosti

I send you an email if I find something interesting about Inst Diagnosti.


Comments

How you think about this?

Leave a comment

Stay informed about Inst Diagnosti.

Receive notifications about Inst Diagnosti in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.